Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1973 Jul 1;138(1):259–277. doi: 10.1084/jem.138.1.259

COMPARATIVE IMMUNOGENICITY AND ENHANCEABILITY OF INDIVIDUAL H-2K AND H-2D SPECIFICITIES OF THE MURINE HISTOCOMPATIBILITY-2 COMPLEX

Ian F C McKenzie 1, George D Snell 1
PMCID: PMC2180541  PMID: 4123828

Abstract

The immunogenicity of single, private H-2 specificities has been tested. In most cases, the specificity was known to be confined either to H-2K or to H-2D. This was accomplished by the appropriate choice, as donor and recipient, or parent of the F1 hybrid recipient, of congenic strains differing at H-2 only, and of recombinant haplotypes in donor and/or recipient. By nearly all tests, the H-2K antigen appeared to be a stronger immunogen than the H-2D antigen. Skin grafts with an H-2K difference showed median survival times (MST) of 9.3–14.5 days; for H-2D the values were 13.8–18.6. The difference was also present, though narrowed, for second-set grafts. H-2K grafts regularly engendered a demonstrable cytotoxic antibody response; with H-2D differences the response was absent or very weak. K end cytotoxic titers after multiple immunizations with lymphoid tissues ranged from 1/32 to 1/2,048, D end titers from 0 to 1/128. Hemagglutination titers showed no clear difference. The results of passive enhancement of skin grafts with H-2 alloantibody produced in donor recipient combinations, identical to those used for the skin grafts showed a different pattern. H-2K, despite its greater immunogenic strength was more easily enhanced than H-2D. Prolongation of MST's for H-2K was 2.4–6.7 days, for H-2D grafts, 0.2–1.5 days.

Full Text

The Full Text of this article is available as a PDF (1,023.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTH R., COUNCE S., SMITH P., SNELL G. D. Strong and weak histocompatibility gene differences in mice and their role in the rejection of homografts of tumors and skin. Ann Surg. 1956 Aug;144(2):198–204. doi: 10.1097/00000658-195608000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bach F. H., Widmer M. B., Bach M. L., Klein J. Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med. 1972 Dec 1;136(6):1430–1444. doi: 10.1084/jem.136.6.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bonmassar E., Goldin A., Cudkowicz G. Differential immunogenicity of H-2 alloantigens: a sensitive immuno-pharmacologic test. Proc Soc Exp Biol Med. 1971 Sep;137(4):1486–1489. doi: 10.3181/00379727-137-35815. [DOI] [PubMed] [Google Scholar]
  4. Boyse E. A., Flaherty L., Stockert E., Old L. J. Histoincompatibility attributable to genes near H-2 that are not revealed by hemagglutination or cytotoxicity tests. Transplantation. 1972 Apr;13(4):431–432. doi: 10.1097/00007890-197204000-00013. [DOI] [PubMed] [Google Scholar]
  5. CUDKOWICZ G., STIMPFLING J. H. HYBRID RESISTANCE CONTROLLED BY H-2 REGION: CORRECTION OF DATA. Science. 1965 Feb 26;147(3661):1056–1056. doi: 10.1126/science.147.3661.1056. [DOI] [PubMed] [Google Scholar]
  6. Corry R. J., Winn H. J., Russell P. S. Heart transplantation in congenic strains of mice. Transplant Proc. 1973 Mar;5(1):733–735. [PubMed] [Google Scholar]
  7. Cullen S. E., Schwartz B. D., Nathenson S. G. The distribution of alloantigenic specificities of native H-2 products. J Immunol. 1972 Mar;108(3):596–600. [PubMed] [Google Scholar]
  8. Dutton R. W. Further studies of the stimulation of DNA synthesis in cultures of spleen cell suspensions by homologous cells in inbred strains of mice and rats. J Exp Med. 1965 Oct 1;122(4):759–770. doi: 10.1084/jem.122.4.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dutton R. W. Spleen cell proliferation in response to homologous antigens studied in congenic resistant strains of mice. J Exp Med. 1966 Apr 1;123(4):665–671. doi: 10.1084/jem.123.4.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Démant P., Nouza K. Different sensitivity of H-2K and H-2D incompatibility to ALS immunosuppression. Folia Biol (Praha) 1971;17(6):410–413. [PubMed] [Google Scholar]
  11. Démant P., Snell G. D., Cherry M. Hemagglutination and cytotoxic studies of H-2. 3. A family of 3-like specificities not in the C crossover region. Transplantation. 1971 Mar;11(3):242–259. [PubMed] [Google Scholar]
  12. Festenstein H., Abbasi K., Sachs J. A., Oliver R. T. Serologically undetectable immune responses in transplantation. Transplant Proc. 1972 Jun;4(2):219–222. [PubMed] [Google Scholar]
  13. Gleichmann E., Gleichmann H. Differential immunogenicity of D- and K-end antigens and its possible significance for HL-A. Transplantation. 1972 Feb;13(2):180–183. doi: 10.1097/00007890-197202000-00021. [DOI] [PubMed] [Google Scholar]
  14. Graff R. J., Hildemann W. H., Snell G. D. Histocompatibility genes of mice. VI. Allografts in mice congenic at various non-H-2 histocompatibility loci. Transplantation. 1966 Jul;4(4):425–437. [PubMed] [Google Scholar]
  15. Jeekel J. J., McKenzie I. F., Winn H. J. Immunological enhancement of skin grafts in the mouse. J Immunol. 1972 Apr;108(4):1017–1024. [PubMed] [Google Scholar]
  16. Klein J. Is the H-2K locus of the mouse stronger than the H-2D locus? Tissue Antigens. 1972;2(3):262–266. doi: 10.1111/j.1399-0039.1972.tb00144.x. [DOI] [PubMed] [Google Scholar]
  17. Klein J., Shreffler D. C. The H-2 model for the major histocompatibility systems. Transplant Rev. 1971;6:3–29. doi: 10.1111/j.1600-065x.1971.tb00457.x. [DOI] [PubMed] [Google Scholar]
  18. Klein J., Widmer M. B., Segall M., Bach F. H. Mixed lymphocyte culture reactivity and H-2 histocompatibility loci differences. Cell Immunol. 1972 Aug;4(4):442–446. doi: 10.1016/0008-8749(72)90045-7. [DOI] [PubMed] [Google Scholar]
  19. Koene R., McKenzie I. F., Painter E., Sachs D. H., Winn H. J., Russell P. S. Soluble mouse histocompatibility antigens. Transplant Proc. 1971 Mar;3(1):231–233. [PubMed] [Google Scholar]
  20. McDevitt H. O., Deak B. D., Shreffler D. C., Klein J., Stimpfling J. H., Snell G. D. Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med. 1972 Jun 1;135(6):1259–1278. doi: 10.1084/jem.135.6.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McKenzie I. F., Koene R., Winn H. J. Mechanism of skin graft enhancement in the mouse. Transplant Proc. 1971 Mar;3(1):711–713. [PubMed] [Google Scholar]
  22. McKenzie I. F., Painter M. E. The antibody response of rabbits to soluble mouse H-2 antigens. J Immunol. 1972 Feb;108(2):352–357. [PubMed] [Google Scholar]
  23. McKenzie I. F., Snell G. D. Immunogenicity and enhancement of normal and tumor tissue in the mouse. Transplant Proc. 1973 Mar;5(1):953–956. [PubMed] [Google Scholar]
  24. Meo T., Vives J., Miggiano V., Shreffler D. A major role for the Ir-1 region of the mouse H-2 complex in the mixed leukocyte reaction. Transplant Proc. 1973 Mar;5(1):377–381. [PubMed] [Google Scholar]
  25. SNELL G. D., JACKSON R. B. Histocompatibility genes of the mouse. II. Production and analysis of isogenic resistant lines. J Natl Cancer Inst. 1958 Nov;21(5):843–877. [PubMed] [Google Scholar]
  26. SNELL G. D., RUSSELL E., FEKETE E., SMITH P. Resistance of various inbred strains of mice to tumor homoiotransplants, and its relation to the H-2 allele which each carries. J Natl Cancer Inst. 1953 Dec;14(3):485–491. [PubMed] [Google Scholar]
  27. STIMPFLING J. H. METHODS FOR DETECTION OF HEMAGGLUTININS IN MOUSE ISOANTISERA. Methods Med Res. 1964;10:22–26. [PubMed] [Google Scholar]
  28. STIMPFLING J. H., RICHARDSON A. RECOMBINATION WITHIN THE HISTOCOMPATIBILITY LOCUS OF THE MOUSE. Genetics. 1965 May;51:831–846. doi: 10.1093/genetics/51.5.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Skoskiewicz M., Chase C., Winn H. J., Russell P. S. Kidney transplants between mice of graded immunogenetic diversity. Transplant Proc. 1973 Mar;5(1):721–725. [PubMed] [Google Scholar]
  30. Snell G. D., Cherry M., Démant P. Evidence that H-2 private specificities can be arranged in two mutually exclusive systems possibly homologous with two subsystems of HL-A. Transplant Proc. 1971 Mar;3(1):183–186. [PubMed] [Google Scholar]
  31. Snell G. D., Cherry M., McKenzie I. F., Bailey D. W. Ly-4, a new locus determining a lymphocyte cell-surface alloantigen in mice. Proc Natl Acad Sci U S A. 1973 Apr;70(4):1108–1111. doi: 10.1073/pnas.70.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Snell G. D., Démant P., Cherry M. Hemagglutination and cytotoxic studies of H-2. I. H-2.1 and related specificities in the EK crossover regions. Transplantation. 1971 Mar;11(3):210–237. doi: 10.1097/00007890-197103000-00002. [DOI] [PubMed] [Google Scholar]
  33. Snell G. D., Graff R. J., Cherry M. Histocompatibility genes of mice. XI. Evidence establishing a new histocompatibility locus, H-12, and new H-2 allele, H-2bc. Transplantation. 1971 Jun;11(6):525–530. [PubMed] [Google Scholar]
  34. Stimpfling J. H., Durham T. Genetic control by the H-2 gene complex of the alloantibody response to an H-2 antigen. J Immunol. 1972 Apr;108(4):947–951. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES